chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Localized redness and swelling just below injection sight. Oral antibiotic from MD.
Patient was given MMR, Varicella, Hep A , Hib, pneumo vaccines at 1 year physical on 9/20/2022.  No history of previous adverse reactions.  Patient had a seizure at 2am the following day that lasted 5-6 minutes.  Afterward he was able to resume sleep and had a second seizure at about 8am that lasted 4-5 minutes.  He was taken to Medical Center for further evaluation.  Per parent, work up and EEG were normal.  He was discharged home after 1 day hospital stay and since then has been at baseline.
Information has been received from a physician concerning a 14 year old female with penicillin allergy and allergy to amoxicillin (+) (AUGMENTIN) who on 30-JUN-2008 was vaccinated with a dose of GARDASIL vaccine (yeast) intramuscularly in the arm (lot number not reported). Concomitant therapy included hepatitis A vaccine (inactive) (HAVRIX). Subsequently the patient experienced hives on her arm, at the injection site and also on her leg (left or right unspecified). Unspecified medical attention was sought. These symptoms lasted about one week. Subsequently, the patient recovered from the event. Additional information has been requested.
nervous; vomiting; anaphylactic shock; she felt like she was having a heart attack; chest pains; confused; kind of like not knowing what was going on; heart racing; stomach pains; anxious; This spontaneous report was received from a currently 50 years old female patient referring to herself. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.  Between 1980 and 1982, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (dose, strength, lot# and expiration date were not provided) via injection route to prevent measles, mumps, and rubella.   Between 1980 and 1982, the patient was administered the vaccine in school and had terrible reactions to the vaccine when she was between 10 and 12 years old. The patient went into anaphylactic shock and felt she was having a heart attack, vomiting, chest pains, confused, kind of like not knowing what was going on, heart racing, stomach pains and anxious. The patient's parents took her to the emergency room and she only remembered that a needle was given in her arm in hospital but not remembered anything else. The patient's mother walked the patient to car to house. The patient was now scheduled to have the coronavirus 2019 (COVID-19) vaccine on Sunday (unspecified) and she was nervous. The patient sought medical attention.   The outcome of the events was recovered. The causality between the events and the suspect therapy was not provided.   Upon internal review, anaphylactic shock and heart attach were determined to be medically significant.
Hospitalization: 1/1/2023 - 1/2/2023 (30 hours).  Presentation to the ED: near syncopal episode.  COVID + date: 1/1/2023 Treatment: asymptomatic; NO TREATMENT INDICIATED.  Discharge to: home.  EN5318 1/29/2021 EN6200 2/19/2021 PAA173697 11/5/2021 FK9893 4/19/2022
Patient developed Henoch Schonlein Purpura  about 13 days after receiving the above vaccines
The report was first received from practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 04-DEC-2017, the patient was vaccinated with ROTATEQ (strength were unknown, lot# N004815 and expiration date 07-OCT-2018) 1 dose form orally for prophylaxis. No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017 was 47 degree Celsius for max 15 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001958.
Next day air headed (zombie like); Hives around vaccine entry left arm to arm pit; Hives at armpit and lower rib cage above stomach; hours after falling asleep repeatedly; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8732) via an unspecified route of administration in the left arm on 28Mar2021 at 10:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included tamsulosin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), SUPER BETA PROSTATE and multivitamin from an unspecified date for an unknown indication. The patient was allergic to amlodipine (MANUFACTURER UNKNOWN) and oxybutynin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 14:00, the patient experienced falling asleep repeatedly. On 29Mar2021, on the next day of vaccination, the patient experienced air-headed (zombie like) and hives around vaccine entry left arm to arm pit and lower rib cage above stomach was seen at bedtime. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event hours after falling asleep repeatedly, air headed (zombie like), hives around vaccine entry left arm to arm pit and hives at armpit and lower rib cage above stomach was recovered on an unspecified date 2021, at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient presented to ER on 10/12/12 with complaint of fever 103 degrees. He was discharged. Seen at PCP office on 10/16/12 for a rash which started on 10/13/12. Flesh colored papules on trunk, bilateral legs and arms. MD diagnosis was probable post-varicella rash. Calamine and BENADRYL as needed for itching.
C/o rash all over body very itchy, x 1 day  No tx given, Comfort measures, Child was exposed to vaccinated person.
No adverse event; 3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old) and NO ADVERSE EVENT (No adverse event) in a 3-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Dec-2022, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (3 years old patient came back for his 2nd dose and was given Moderna Bivalent 6 months -5 years old).    No concomitant medications were reported.   No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jan-2023: Follow-up document included no new information.
Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying; Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying) and INDURATION (Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2012, the patient experienced INDURATION (Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying). On 02-May-2021, the patient experienced PRURITUS (Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying). At the time of the report, PRURITUS (Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying) and INDURATION (Itchy bumps on her ear/ itchy bumps on her back/ itchy bumps on her extremities multiplying) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient plans to take allergy medications as treatment for the events.
12/21/20 fever 101.9,  body aches,  lower back pain,  congestion and  cough -- tylenol . 12/22/2020 mortin for fever AM 101.9 some relief,  symptoms less today.
myocarditis; This is a spontaneous report received from contactable reporter(s) (Pharmacist). Other Case identifier(s): 2023NVX-US-000000288.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown".  Additional information: On 09Mar2022, it was reported that a patient stated treatment on an unspecified date with Pfizer BioNTech COVID-19 Vaccine at an unspecified dose/frequency for covid 19 vaccination. It was reported the patient developed myocarditis as a result of the vaccine. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On 5/3/2022, I began having symptoms that included a minor sore throat and postnasal drip. Later in the day, I also had a little bit of a dry cough. All of the symptoms persisted for the next day and a half. I took some cold medicine, which only helped alleviate some of the postnasal drip, though for the most part, the symptoms persisted. On the morning of 5/5/2022, I took a home test for COVID, and the result was positive. About two hours after taking the first home test, I took another home test, and the result again was positive. Late in the afternoon that same day, I went to an urgent care clinic and took a PCR test, which also yielded a positive result. I was prescribed a 5-day course of molnupiravir. By the time I finished the treatment, the sore throat and postnasal drip were gone, though I still had a persistent dry cough that gradually diminished over the following several days. During the period of my recuperation, I made it a point to keep myself completely isolated for five days, though I did associate some with my family after that period and took precautionary measures like masking.
ED to Hosp-Admission  Current  10/2/2021 - present (12 days) Pneumonia  Principal problem Patient is a 86 y.o. male on hospital day number 0   Principal Problem:   Pneumonia Altered mental state Atrial fibrillation with slow ventricular response Prostate cancer with metastasis Troponin elevation Mild rhabdomyolysis Hypokalemia Generalized weakness    Plan      Chief Complaint Patient presents with ? Altered Mental Status ? Fall     1. Pneumonia?patient has a cough.  X-ray is concerning for possible pneumonia.  I will place him on community-acquired pneumonia.  He was apparently recently started on Vantin which may have been for recently diagnosed community-acquired pneumonia as well. 2. Atrial fibrillation/flutter with slow ventricular response?he had EKG demonstrating atrial fibrillation in January of this year.  He is not on any anticoagulant.  Will consult cardiology as he also now has a slow ventricular response.  He is not on any negative chronotropic medications. 3. Altered mental state?patient has no recollection of what been transpiring recently.  His long-term memory seems fairly intact.  CT scan of the head was unremarkable.  Confusion may be secondary to underlying pneumonia.  We will continue to monitor.  He does not have any focal motor deficits currently. 4. Prostate cancer with bony metastasis?continue with Zytiga. 5. Troponin elevation?likely demand ischemia in the setting of having been down for a day or so as well as having pneumonia.  Will obtain echo in the morning and continue to trend enzymes. 6. Mild rhabdomyolysis?secondary to have been down.  We will continue to trend.  Levels are now very high. 7. Hypokalemia?replete. 8. Generalized weakness-patient has a baseline gait dysfunction.  The family has been contemplating placement.  Will order physical and Occupational Therapy and consult case management.    History of Present Illness     Patient is an 86 y.o. male.    Comes in today after being found down.  Patient lives by himself.  He has metastatic prostate cancer.  Family has spoke with him yesterday but not since.  Today he was found on the floor covered in feces with traumatic skin tears.  He was unable to get up.  Patient was brought into the emergency room where work-up was notable for possible pneumonia on x-rays.  He was very confused and not able to provide any history and has no recollection of what transpired recently.  Patient's functional capacity has been poor recently with a gait dysfunction and family has been contemplating sending him for placement.  Patient currently denies any pain.  Not able to provide any additional information.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. In November 2014, the patients were vaccinated with improperly stored RECOMBIVAX HB 2.5 microgram/0.5ml (dose, lot number, expiration date were not reported). No adverse effects were reported. Additional information has been requested.
Dizziness sore left shoulder Narrative:  employee states: she only suffered slight dizziness for 2 days and a very sore left shoulder for 3 days. She was unable to sleep on the left side the first 2 nights due to soreness
Muscle pain and some joint pain and nerve pain. I have shortness of breath since then going up hill, I don't have any other condition that would cause that. I have respiratory distress. The nerve pain goes down my arms and to my thumbs and my wrist and the palm. It is a shooting pain. Something that might be relevant is that there is a possibility I had a slight case of COVID in Spring of 2020.
Symptomatic with congestion, runny nose, HA and body aches since 12/19/21. He initially tested negative then positive for Covid on 12/21/21. He will continue to isolate until 12/29/21 and follow up with hotline. Antibody testing ordered.
Reported that her arm was swollen, warm and red.  Took a month or so to go back to normal.
Non stop crying for 4 hrs than on/off crying until 4 am! Then slept most of 3/1/13. Fever of 102.2 in evening of 2/28/13 and 102.1 in arm on 3/1/13. Blood in stool day after and for 2 days (03/01/13 and 03/02/13).
Rapid heart beat; Joint pain; Muscle pain; Fatigue; Swelling in the area of shot; This is a spontaneous report from a contactable consumer (patient).  A 74-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 20Feb2021 00:30 (Batch/Lot Number: EL9267, Expiry date: unknown, Age at the vaccination: 74-year-old) as dose 2, single for covid-19 immunization. Medical history included asthma and known allergies: sulfur drugs, papaya, mango. Concomitant medications included metformin, procaterol hydrochloride (PRO-AIR), ergocalciferol (VIT D), montelukast and losartan; all drugs taken for an unspecified indication, start and stop date were not reported. Historical vaccine included patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Right on 27Jan2021 12:30 AM (Batch/Lot Number: EL8982, Expiry date: unknown, Age at the vaccination: 74-year-old) as dose 1, single for covid-19 immunization and experienced after the first shot the patient had rapid heartbeat for four days. After the first shot, the patient had rapid heartbeat for four days. Covid prior vaccination and covid tested post vaccination was mentioned as no. On 20Feb2021 14:30, the patient experienced rapid heartbeat, joint pain, muscle pain, fatigue, swelling in the area of the shot. The patient underwent lab tests and procedures included heartbeat with rapid results on 20Feb2021. The patient was not received any treatment with respect to events. The outcome of events was recovering.  Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
CHEST TIGHTNESS AND DISCOMFORT; SLIGHT SHORTNESS OF BREATH; DRY COUGH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the patient experienced chest tightness and discomfort. On 09-APR-2021, the patient experienced slight shortness of breath. On 09-APR-2021, the patient experienced dry cough. On 12-APR-2021, Laboratory data included: Chest X-ray (NR: not provided) Normal, Echocardiogram (NR: not provided) Normal, Electrocardiogram (NR: not provided) Normal, and Fibrin D dimer (NR: not provided) Normal. On 14-APR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chest tightness and discomfort, slight shortness of breath, and dry cough. This report was non-serious.
Felt tired but good Saturday afternoon. Sunday felt good, sore arm but thankful I didn?t get sick. Monday morning 4am woke in pain in lower back. Felt Like a contraction. It was hard to rotate side to side, could not bend or twist. Stairs were very painful. Spasms in lower back would occur when back muscles were engaged, even lifting my arms or holding a cup of coffee caused strain and tension to my back.  Wore salan pas patches to help with aches and at the end of the day, Took a muscle relaxer and went to bed early.  Pain has subsided Tuesday. Still bending and twisting were tolerable and spasms lessen by 50%. Took motrin   and  slept. Wednesday walking is easier bending is better. Sit down to work and after 1/2 of not moving back began spasming.
PATIENT RECEIVED INJECTION AND WAS WAITING FOR THE 15 MINUTES AFTER INJECTION. PATIETN HAD BEEN TALKING TO OTHER PATIENTS IN ROOM WHEN PATIENT APPEARED TO BE MOVING IN CHAIR AND THEN FELL. PATIENT WAS UNRESPONSIVE  AND SHOWING SIGNS OF RIGHT SIDED NEGLECT. PATIENT WAS UNABLE TO COMMUNICATE OR SPEAK.  PATIENT WAS IMMEDIATELY TAKEN TO THE EMERGENCY ROOM WHERE HE WAS EXAMINED AND WAS THEN TRANSFERED TO A HIGHER LEVEL OF CARE DUE TO STROKE.
Patient presented with redness, itching, hive-like reaction at injection site in right arm. Patient reported he started itching, burning, redness, and swelling at site. Patient experienced brief shortness of breath but resolved. No fever or chills were reported by patient. Dyspnea.
Patient was awakened at 0400 on 3/18/2021, with shortness of breath and her entire right side hurting.  Pain was in the lower right chest, right upper abdominal quadrant and right flank pain. Presented to the ED. CT of chest /abdomen showed pulmonary embolus in the right lower lung.  Patient is being treated with Eliquis and was sent home from the ED on 3/18.
I received my injection DTP on Sept 14 around 3p on 9/18 started with upper airway congestion with fatigue and backaches low grade temp, dizziness on the 9/18 told employee health nurse on 9/21 still no better treating symptomatic and on 9/23 severe HA, muscle aches and increase BP 30 minutes above normal. Went Primed treated and Decadron shot antibiotics and upper airway continue coughing noted.
(L) deltoid area swelling, warmth, redness and itching about 1 hr after vaccination with flu. Pr. took BENADRYL and itchiness decreased. Call to pt next day-symptoms improving.
shaking, altered consciousness Narrative:  One day after pt received his first covid vaccine, pt experienced upper extremity shaking leading to ED visit and subsequent hospitalization with concern for seizure. Examination and labs were not consistent with seizure. He had features of lewy body disease and parkinsonism. Labs were significant for leukocytosis, but pt had no other signs/symptoms of infection or findings to indicate a source of infection. Pt referred to Neurology.
This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (had them in 2013 and lasted for 6 to 7 weeks). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional details were provided as follows: The case was self reported by the patient. The age at vaccination was not reported. The reporter stated that, shingles hurt so bad, he/she went and got the shot after he/she had got over the earlier shingles and thought that was it. But just before thanksgiving day in the reporting year he/she came down with shingles again. The reporter tried everything people had suggested and what the Doctor gave and thought he/she was getting better but still had them and they still hurt so bad. The reporter adviced to take the shot as soon as possible if not gotten yet and also to have a short talk to doctor. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Swelling and sore - 5 days with sore, itchy eyes. Fever 6 hr. Headache 3 days. Fatigue - 5 days. Nausea - 15 days and Thirsty - 2 days. Dizzy - when move - 3 days worth, then another week and short of breath. I could not do 1 flight of stairs when usually do 10 flights or more.